Results 231 to 240 of about 18,082,299 (299)

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson's disease: A French survey. [PDF]

open access: yesClin Park Relat Disord
Barré T   +7 more
europepmc   +1 more source

Expert Consensus on Vitamin B6 Therapeutic Use for Patients: Guidance on Safe Dosage, Duration and Clinical Management. [PDF]

open access: yesDrug Healthc Patient Saf
Schellack N   +5 more
europepmc   +1 more source

AI-enabled drug prediction and gene network analysis reveal therapeutic use of vorinostat for Rett Syndrome in preclinical models. [PDF]

open access: yesCommun Med (Lond)
Novak R   +17 more
europepmc   +1 more source

Therapeutic use of music listening in patients undergoing invasive coronary procedures: A meta-analysis. [PDF]

open access: yesWorld J Cardiol
Siddiqi AK   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy